Status:
ACTIVE_NOT_RECRUITING
The Corona and COVID-19 Study in Telemark and Agder
Lead Sponsor:
Sykehuset Telemark
Collaborating Sponsors:
Sorlandet Hospital HF
Norwegian Institute of Public Health
Conditions:
Covid19
Eligibility:
All Genders
18-85 years
Brief Summary
Through SARS-CoV-2 IgG testing of PCR positive and negative cases the study will follow the COVID-19 immune response by monitoring the SARS-CoV-2 IgG antibody levels over a period of two years. Furthe...
Detailed Description
Objectives The main objectives are: 1. Monitor the incidence of COVID-19 and the development of the SARS-CoV-2-IgG levels of cases in Agder and Telemark over a period of two years (WP1). 2. Identify...
Eligibility Criteria
Inclusion
- Age 18 - 85 years
- Performed SARS-CoV-2 PCR test
Exclusion
- Non-Norwegian speakers.
- Deceased
- inability to answer questionnaire due to dementia or similar conditions
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04514003
Start Date
July 1 2020
End Date
December 31 2035
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Telemark Hospital
Skien, Vestfold and Telemark, Norway, 3710